Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A14 (FAM90A14) is part of the FAM90A gene family, which is primate-specific and appears to have expanded through lineage-specific duplications and rearrangements[1][7]. FAM90A14 is mapped as a protein-coding gene, but also referred to as a pseudogene in some contexts[1]. According to current data, its exact biological function remains unknown, no molecular pathways are ascribed to it, and there are no reports of therapeutic relevance, drug interactions, or biomarker status[1][3][7][6]. An important paralog is FAM90A15[1]. FAM90A14 is not classified within any major molecular target categories such as receptor, enzyme, transporter, or transcription factor, and remains functionally uncharacterized. Its pseudogene annotation implies a lack of—or uncertainty surrounding—protein expression and functional activity, common with several members of the primate-specific FAM90A family[1][3][7]. There is currently no evidence supporting its status as a druggable, disease-related, or validated therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A14 (FAM90A14).